Sofinnova Investments’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-113,757
Closed -$6.87M 78
2023
Q4
$6.87M Sell
113,757
-179,048
-61% -$10.8M 0.38% 39
2023
Q3
$16.7M Buy
+292,805
New +$16.7M 1.05% 24